Search Results - A. E. Karateev
- Showing 1 - 20 results of 168
- Go to Next Page
-
1
Problems of pain and quality of life in rheumatoid arthritis: focus on baricitinib by A. E. Karateev
Published 2020-09-01Modern therapy for rheumatoid arthritis (RA) allows not only to reduce the activity of immune-mediated inflammation and slow down the progression of the disease, but also to quickly eliminate the main symptoms that cause the most concern to patients, such as pain, functional disorders, fatigue. This...
Get full text
Article -
2
Glycosaminoglycan-peptide complex in the treatment of knee and hip osteoarthritis: from the past to the future by A. E. Karateev
Published 2020-02-01The glycosaminoglycan-peptide complex (GPC) Rumalon is a popular injectable drug used to treat osteoarthritis (OA). GPC was one of the world’s first drugs designed for the pharmacotherapy of this disease. The drug has been rigorously tested for efficacy and safety in a series of international placeb...
Get full text
Article -
3
NSAID GASTROPATHY: CHANGES OVER 12 YEARS by A E Karateev
Published 2011-06-01Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most popular medications to relieve the symptoms of rheumatoid arthritis (RA). However, NSAIDs can cause serious gastrointestinal, cardiovascular, and renal complications. To take into account risk factors and to use safer NSAIDs and gastroprotec...
Get full text
Article -
4
Lactulose administration for correction of stool disturbances in patients with rheumatic diseases by A E Karateev
Published 2008-12-01Objective. To study efficacy and tolerability of Normase® (lactulose, Doctor Reddy’s laboratories) for correction of stool disturbances in pts with rheumatic diseases (RD). Material and methods. 50 pts with RD (female with mean age 64,2+19,6 years) suffering from constipation (stool frequency less t...
Get full text
Article -
5
-
6
Analgesic therapy and a problem of comorbidity by A. E. Karateev
Published 2019-09-01Analgesic therapy is an essential element of combination treatment in patients with rheumatic diseases (RDs). However, pain killers can cause serious complications. This risk is especially great in patients with comorbidities. Therefore, the individual choice of pharmacological agents for controllin...
Get full text
Article -
7
What is new? An overview of the 2016 international publications on the efficacy and safety of nonsteroidal anti-inflammatory drugs by A. E. Karateev
Published 2017-03-01Nonsteroidal anti-inflammatory drugs (NSAIDs) are the mainstay of pathogenetic therapy for acute and chronic pain associated with rheumatic diseases. It would seem that NSAIDs are well studied: their pharmacological properties are known; the fields of their applications, the efficacy of the drugs in...
Get full text
Article -
8
Analgesics in rheumatic diseases – a necessary component of therapy aimed at improving the quality of life by A. E. Karateev
Published 2022-10-01Control of chronic pain is one of the main elements of the complex therapy of rheumatic diseases (RD). The use of analgesics is of fundamental importance for the management of patients with osteoarthritis (OA), since a unified system of pathogenetic therapy has not yet been developed for this diseas...
Get full text
Article -
9
Improving the efficacy of musculoskeletal pain therapy: the role of B-group vitamins combination (descriptive review) by A. E. Karateev
Published 2025-06-01Controlling acute and chronic musculoskeletal pain (MSP) is a priority in the management of patients with musculoskeletal disorders. This includes widespread conditions such as non-specific back pain (NSBP), osteoarthritis (OA), and periarticular soft tissue disorders, affecting over 1 billion peopl...
Get full text
Article -
10
Difficult-to-treat osteoarthritis – justification for multimodal treatment tactics by A. E. Karateev
Published 2023-12-01Effective pain control is the most important clinical task in the treatment of osteoarthritis (OA). The International Expert Council, which discussed the possibility of introducing the principle of "treatment to target" to OA treatment, recognized the PASS (patient acceptable symptoms stat...
Get full text
Article -
11
The therapeutic potential of etoricoxib in clinical practice by A. E. Karateev
Published 2020-03-01Etoricoxib is one of the most popular representatives of a group of nonsteroidal anti-inflammatory drugs (NSAIDs), which is widely used in Russia and other countries of the world. It is a highly selective cyclooxygenase 2 inhibitor that has a rapid and pronounced analgesic effect, a high antiinflamm...
Get full text
Article -
12
Naproxen: A universal analgesic with a minimal risk of cardiovascular events by A. E. Karateev
Published 2016-06-01Nonsteroidal anti-inflammatory drugs (NSAIDs) are a main tool used in real clinical practice to relieve acute pain and to control major symptoms in chronic diseases of the joint and spinal column. They are effective and easy-to-use; however, they may cause adverse reactions (ARs) that require carefu...
Get full text
Article -
13
Pharmacotherapy for lumbago by A.E. Karateev
Published 2014-05-01Nonspecific low back pain (NLBP) is one of the most common rheumatic disorders; it is responsible for the greatest number of patients seeking medical advice. Unfortunately, there is neither a generally acknowledged viewpoint on the nature of this pathology nor a unified conception of its treatment i...
Get full text
Article -
14
ETODOLAC, A WELL KNOWN AND ACTIVELY USED DRUG IN DIFFERENT COUNTRIES OF THE WORLD. WOULD IT BE TIME FOR US? by A. E. Karateev
Published 2019-09-01Etodolac is a nonsteroidal anti-inflammatory drug (NSAID), a moderately selective cyclooxygenase-2 inhibitor, which has been already used in clinical practice for more than 30 years as a universal analgesic and anti-inflammatory agent. Etodolac has proven itself in relieving acute pain associated wi...
Get full text
Article -
15
Destabilized hypertension as a complication of therapy with nonsteroidal anti-inflammatory drugs: the importance of the problem by A. E. Karateev
Published 2018-06-01Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most popular tool to combat pain. Unfortunately, NSAIDs can cause various adverse reactions, among these one of the most common ones is the development or destabilization of hypertension. Controlled and observational studies have shown that the u...
Get full text
Article -
16
Local injection therapy with hyaluronic acid preparations: in focus of rheumatologists and orthopedic traumatologists by A. E. Karateev
Published 2024-06-01Hyaluronic acid (HA) is an effective and safe medication for local injection therapy (LIT) widely used in the treatment of osteoarthritis (OA) of large joints. The therapeutic effect of HA is determined both by the replacement of the lubricating function of natural hyaluronate (viscosupplementation)...
Get full text
Article -
17
To the 100th anniversary of the birth of academician V.A. Nasonova. Pain control in rheumatic diseases: Past and future by A. E. Karateev
Published 2023-04-01Throughout the history of rheumatology, the attitude to pain has changed significantly. In the XIX and early XX centuries, pain was considered only as one of the symptoms, the control of which is secondary to the etiotropic and pathogenetic therapy of rheumatic diseases (RD). However, already in the...
Get full text
Article -
18
Celecoxib in rheumatic diseases: possibilities and prospects. Brief descriptive survey by A. E. Karateev
Published 2024-10-01Chronic pain is the main manifestation of rheumatic diseases (RD), it determines the main complaints and worsens the quality of life of patients. The problem of effective control of chronic pain in rheumatology remains a current issue despite the successes in the development of new drugs for pathoge...
Get full text
Article -
19
Hyaluronic acid in rheumatic disorders of the periarticular soft tissues: a brief descriptive review by A. E. Karateev
Published 2022-10-01Periarticular soft tissue disorders (PSTD) are typical manifestation of immunoinflammatory rheumatic diseases, primarily spondyloarthritis. However, in real clinical practice, physicians involved in the management of patients with musculoskeletal diseases often have to deal with "non-systemic&q...
Get full text
Article -
20
The problem of musculoskeletal pain: what is interesting for the practitioner? Data of a survey of 846 Russian physicians by A. E. Karateev
Published 2019-05-01The paper presents the results of a survey of 846 Russian physicians (neurologists, rheumatologists, orthopedic traumatologists, general practitioners, and therapists), whose work is associated with the treatment of musculoskeletal pain. The physicians have been asked to answer which topics they con...
Get full text
Article